Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michele J. Sadler"'
Autor:
Michele J. Sadler
Recent developments, concerning the regulation of health claims in Europe have been a slowing of health-claim applications through the available application routes i.e. for reduction of disease risk claims, children’s development and health claims,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5097da699747e32c3191e919f579a0f3
https://doi.org/10.1016/b978-0-08-100922-2.00001-2
https://doi.org/10.1016/b978-0-08-100922-2.00001-2
Autor:
Michele J. Sadler
The four health claims covered in this chapter are examples of claims that have been authorised for use in the European Union but are not in widespread use for various reasons. The claims are for activated charcoal and ‘contributes to reducing exce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3eb48655fa2218593c74509424a2839
https://doi.org/10.1016/b978-0-08-100922-2.00016-4
https://doi.org/10.1016/b978-0-08-100922-2.00016-4
Autor:
Ursula Arens, Heike A. Bischoff-Ferrari, Eric Chappuis, Jess Funnell, Philippa S. Gibson, Klaus G. Grunert, Janice I. Harland, Sophie Hieke, Nicole J. Kellow, Sarah Kuczora, Susan A. Lanham-New, Katherine M. Livingstone, Michele J. Sadler, Stephan Theis, Karen Z. Walker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::736c0cc5abaaa4c1ad05c58d0a4b721e
https://doi.org/10.1016/b978-0-08-100922-2.00020-6
https://doi.org/10.1016/b978-0-08-100922-2.00020-6
Autor:
Jess Funnell, Michele J. Sadler
This chapter discusses the authorised EU health claim for chitosan in relation to its role in the maintenance of normal blood cholesterol levels. Due to the associated risk of elevated blood cholesterol levels with cardiovascular disease, the develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67412f4b313ce84fe23cff1098fc8e42
https://doi.org/10.1016/b978-0-08-100922-2.00011-5
https://doi.org/10.1016/b978-0-08-100922-2.00011-5
Two reduction of disease risk health claims were authorised for use in the European Union in 2014, based on an EFSA opinion published in 2009, a further opinion considering the conditions of use, and two opinions reassessing the tolerable upper intak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43a1f45e39a9d4bb4b5b62fcb66bc24c
https://doi.org/10.1016/b978-0-08-100922-2.00003-6
https://doi.org/10.1016/b978-0-08-100922-2.00003-6
Autor:
Michele J. Sadler
Diet has an important role in maintaining dental health, and there is a general need for more research to understand the impact of different foods and drinks on dental endpoints. An EU health claim has been authorised for a range of modified, non-alc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec84dece1cfd0ba0561cf56495007bda
https://doi.org/10.1016/b978-0-08-100922-2.00007-3
https://doi.org/10.1016/b978-0-08-100922-2.00007-3
Autor:
Michele J. Sadler
A reduction of disease risk health claim that ‘Supplemental folic acid intake increases maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects in the developing foetus’ was authorised in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9708a90b8df21f3e04c54ab1f105afaa
https://doi.org/10.1016/b978-0-08-100922-2.00005-x
https://doi.org/10.1016/b978-0-08-100922-2.00005-x
A reduction of disease risk health claim was authorised for use in the European Union in 2014, based on an EFSA opinion published in 2011 and a further opinion revising the tolerable upper intake level for vitamin D in the EU. EFSA concluded that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f28c75185324a20d7650289cc522097a
https://doi.org/10.1016/b978-0-08-100922-2.00004-8
https://doi.org/10.1016/b978-0-08-100922-2.00004-8